Chemogenetic Suppression of the Subthalamic Nucleus Induces Attentional Deficits and Impulsive Action in a Five-Choice Serial Reaction Time Task in Mice.
5-choice serial reaction time task
DREADD
attention
impulsivity
subthalamic nucleus
Journal
Frontiers in systems neuroscience
ISSN: 1662-5137
Titre abrégé: Front Syst Neurosci
Pays: Switzerland
ID NLM: 101477946
Informations de publication
Date de publication:
2020
2020
Historique:
received:
31
03
2020
accepted:
26
05
2020
entrez:
28
7
2020
pubmed:
28
7
2020
medline:
28
7
2020
Statut:
epublish
Résumé
The subthalamic nucleus (STN), a key component of the basal ganglia circuitry, receives inputs from broad cerebral cortical areas and relays cortical activity to subcortical structures. Recent human and animal studies have suggested that executive function, which is assumed to consist of a set of different cognitive processes for controlling behavior, depends on precise information processing between the cerebral cortex and subcortical structures, leading to the idea that the STN contains neurons that transmit the information required for cognitive processing through their activity, and is involved in such cognitive control directly and dynamically. On the other hand, the STN activity also affects intracellular signal transduction and gene expression profiles influencing plasticity in other basal ganglia components. The STN may also indirectly contribute to information processing for cognitive control in other brain areas by regulating slower signaling mechanisms. However, the precise correspondence and causal relationship between the STN activity and cognitive processes are not fully understood. To address how the STN activity is involved in cognitive processes for controlling behavior, we applied Designer Receptors Exclusively Activated by Designer Drugs (DREADD)-based chemogenetic manipulation of neural activity to behavioral analysis using a touchscreen operant platform. We subjected mice selectively expressing DREADD receptors in the STN neurons to a five-choice serial reaction time task, which has been developed to quantitatively measure executive function. Chemogenetic suppression of the STN activity reversibly impaired attention, especially required under highly demanding conditions, and increased impulsivity but not compulsivity. These findings, taken together with the results of previous lesion studies, suggest that the STN activity, directly and indirectly, participates in cognitive processing for controlling behavior, and dynamically regulates specific types of subprocesses in cognitive control probably through fast synaptic transmission.
Identifiants
pubmed: 32714157
doi: 10.3389/fnsys.2020.00038
pmc: PMC7344274
doi:
Types de publication
Journal Article
Langues
eng
Pagination
38Informations de copyright
Copyright © 2020 Nishioka, Hamaguchi, Yawata, Hikida and Watanabe.
Références
Brain Res. 1976 Oct 22;115(3):485-91
pubmed: 61785
Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80
pubmed: 12373437
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7837-42
pubmed: 24821804
Neurosci Res. 2002 Jun;43(2):111-7
pubmed: 12067746
Exp Neurol. 2012 Jan;233(1):292-302
pubmed: 22056941
Arch Neurol. 2004 Jan;61(1):89-96
pubmed: 14732625
Development. 2003 Dec;130(25):6375-85
pubmed: 14623826
J Neurosci. 2006 Mar 1;26(9):2424-33
pubmed: 16510720
J Neurosci. 2013 Mar 13;33(11):4804-14
pubmed: 23486951
Cell Rep. 2017 Feb 14;18(7):1817-1830
pubmed: 28199851
J Comp Neurol. 2013 Jun 15;521(9):2125-46
pubmed: 23595816
Front Psychiatry. 2018 Jul 11;9:302
pubmed: 30050474
Nat Protoc. 2013 Oct;8(10):1985-2005
pubmed: 24051960
Cell. 2016 Jan 14;164(1-2):208-218
pubmed: 26771492
Neuroscience. 2005;130(1):1-15
pubmed: 15561420
Ann Neurol. 2009 Dec;66(6):817-24
pubmed: 20035509
Psychopharmacology (Berl). 2006 Jul;187(1):73-85
pubmed: 16767417
J Neurophysiol. 1999 Aug;82(2):925-33
pubmed: 10444687
Behav Brain Res. 1983 Sep;9(3):361-80
pubmed: 6639741
Mov Disord. 2015 Feb;30(2):128-40
pubmed: 25297382
Rev Neurosci. 2013;24(2):125-38
pubmed: 23327862
Science. 2007 Nov 23;318(5854):1309-12
pubmed: 17962524
Nature. 2007 Jan 11;445(7124):168-76
pubmed: 17151600
Nat Protoc. 2008;3(5):759-67
pubmed: 18451784
Behav Brain Res. 2003 Nov 30;146(1-2):105-19
pubmed: 14643464
Psychopharmacology (Berl). 1999 Jan;141(1):57-65
pubmed: 9952065
Dev Biol. 2004 Mar 1;267(1):93-108
pubmed: 14975719
Science. 2009 Apr 17;324(5925):354-9
pubmed: 19299587
Lancet Neurol. 2009 Jan;8(1):67-81
pubmed: 19081516
J Neurosci. 2012 Feb 15;32(7):2453-60
pubmed: 22396419
Neuropsychopharmacology. 2017 May;42(6):1315-1325
pubmed: 27748741
J Neurosci. 2017 Jul 12;37(28):6786-6796
pubmed: 28607168
Mol Cell Neurosci. 2008 Apr;37(4):696-707
pubmed: 18206388
Clin Neurophysiol. 2004 Jun;115(6):1239-48
pubmed: 15134690
Trends Neurosci. 1990 Jul;13(7):266-71
pubmed: 1695401
J Comp Neurol. 2014 Dec 15;522(18):4043-56
pubmed: 25048050
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5163-8
pubmed: 17360345
J Neurosci. 1995 Oct;15(10):6562-75
pubmed: 7472418
J Neurosci. 2002 Mar 1;22(5):1905-13
pubmed: 11880520
J Neurosci. 2014 Feb 5;34(6):2264-75
pubmed: 24501365
J Cogn Neurosci. 2006 Apr;18(4):626-36
pubmed: 16768365
Brain Res Brain Res Rev. 1995 Jan;20(1):128-54
pubmed: 7711765
Science. 2017 May 26;356(6340):853-859
pubmed: 28546212
Annu Rev Neurosci. 1990;13:25-42
pubmed: 2183676
Neuroscience. 2014 Jun 13;270:212-25
pubmed: 24755486
Eur J Neurosci. 2001 Apr;13(8):1609-16
pubmed: 11328354
Neuropsychopharmacology. 2016 Mar;41(4):1014-23
pubmed: 26224620
Science. 2011 Jul 29;333(6042):637-42
pubmed: 21798952
Neuron. 2012 Dec 6;76(5):1030-41
pubmed: 23217750
Am J Psychiatry. 2001 Nov;158(11):1783-93
pubmed: 11691682
J Comp Neurol. 2007 Apr 10;501(5):703-15
pubmed: 17299752
Brain Res. 2004 May 22;1008(2):198-204
pubmed: 15145757
Curr Opin Neurobiol. 2012 Feb;22(1):54-60
pubmed: 22119143
J Neurosci. 2001 Aug 1;21(15):5764-72
pubmed: 11466448
Nat Biotechnol. 2003 May;21(5):562-5
pubmed: 12665802
Eur J Neurosci. 2007 Feb;25(4):1187-94
pubmed: 17331214
eNeuro. 2016 Sep 29;3(5):
pubmed: 27699212
Eur J Neurosci. 1997 Oct;9(10):2086-99
pubmed: 9421169
Lancet. 1995 Jan 14;345(8942):91-5
pubmed: 7815888